Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses
Andrew C. Tremain, Rachel P. Wallace, Kristen M. Lorentz, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 9, pp. 1142-1155
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Identification of indirect CD4+ T cell epitopes associated with transplant rejection provides a target for donor-specific tolerance induction
Zhuldyz Zhanzak, Aileen C. Johnson, P. S. Foster, et al.
Immunity (2025)
Closed Access | Times Cited: 2
A Self-Cascade Penetrating Brain Tumor Immunotherapy Mediated by Near-Infrared II Cell Membrane-Disrupting Nanoflakes via Detained Dendritic Cells
Bhanu Nirosha Yalamandala, Yu-Jen Chen, Ya‐Hui Lin, et al.
ACS Nano (2024) Vol. 18, Iss. 28, pp. 18712-18728
Open Access | Times Cited: 14
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice
Shijie Cao, Erica Budina, Michal M. Raczy, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 5, pp. 611-627
Open Access | Times Cited: 13
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Sequential immunotherapy: towards cures for autoimmunity
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 12
Therapeutic synthetic and natural materials for immunoengineering
Anna Slezak, Kevin Chang, Samir Hossainy, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1789-1822
Open Access | Times Cited: 11
Emerging strategies for nanomedicine in autoimmunity
Ajay S. Thatte, Margaret M. Billingsley, Drew Weissman, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115194-115194
Closed Access | Times Cited: 10
Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles
Yang Liu, Jun Li, Baowen Zhang, et al.
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Clinical perspective on topical vaccination strategies
Petya Popova, Sunny P. Chen, Suiyang Liao, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115292-115292
Open Access | Times Cited: 8
A Self‐Cascading Catalytic Therapy and Antigen Capture Scaffold‐Mediated T Cells Augments for Postoperative Brain Immunotherapy
Bhanu Nirosha Yalamandala, Thrinayan Moorthy, Zhuo‐Hao Liu, et al.
Small (2024)
Closed Access | Times Cited: 7
Can autoimmune diseases be cured? Scientists see hope at last
Cassandra Willyard
Nature (2024) Vol. 625, Iss. 7996, pp. 646-648
Open Access | Times Cited: 6
Vaccines for immune tolerance against autoimmune disease
April Kim, Fang Xie, Omar A. Abed, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115140-115140
Open Access | Times Cited: 11
Exploring the Frontiers of Diabetes Vaccination
Mithilesh Kumar, Apoorva Wasnik, Vidya Sagar, et al.
Indian Journal of Community Medicine (2025)
Open Access
Beyond Conventional Approaches: The Revolutionary Role of Nanoparticles in Breast Cancer
Mohan Liu, Yusi Wang, Yan Li, et al.
MedComm – Biomaterials and Applications (2025) Vol. 4, Iss. 2
Open Access
Anti-Idiotypic mRNA Vaccine to Treat Autoimmune Disorders
Sarfaraz K. Niazi
Vaccines (2023) Vol. 12, Iss. 1, pp. 9-9
Open Access | Times Cited: 8
A citrullinated antigenic vaccine in treatment of autoimmune arthritis
Jin Xu, Tianya Dong, Qian Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 18, pp. 2920-2929
Open Access | Times Cited: 3
Engineering Antigen-Specific Tolerance to an Artificial Protein Hydrogel
Peter B. Rapp, Joshua A. Baccile, Rachel P. Galimidi, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 4, pp. 2188-2199
Open Access | Times Cited: 2
Engineering antigen-presenting cells for immunotherapy of autoimmunity
Clinton Smith, Zhenyu Wang, Jamal S. Lewis
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115329-115329
Closed Access | Times Cited: 2
The role of autoantibodies in bridging obesity, aging, and immunosenescence
Taylor R. Valentino, Nan Chen, Priya Makhijani, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics
Rachel P. Wallace, Kirsten C. Refvik, Jennifer T. Antane, et al.
Cell Reports Medicine (2023) Vol. 5, Iss. 1, pp. 101345-101345
Open Access | Times Cited: 4
Uncloaking the viral glycocalyx: How do viruses exploit glycoimmune checkpoints?
Anthony J. Domma, Lauren A. Henderson, Jeffery A. Nurdin, et al.
Advances in virus research (2024), pp. 63-110
Open Access | Times Cited: 1
Inverse vaccines - Friend, Not Foe: How Inverse Vaccines Tackle Autoimmune Diseases
Rumiana Tenchov, Qiongqiong Angela Zhou
(2024)
Open Access | Times Cited: 1
Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis
Gabriel Bsteh, Assunta Bianco, Tobias Zrzavy, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 4, pp. 564-578
Open Access | Times Cited: 1
Suppression of autoimmune arthritis and neuroinflammation via an amino acid-conjugated butyrate prodrug with enhanced oral bioavailability
Shijie Cao, Erica Budina, Michal M. Raczy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
DC-targeting lentivectors for cancer immunotherapy
Ester Gea‐Mallorquí, Sarah Rowland–Jones
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top